- Confirm that the patient has a documented recent drop in alcohol intake and is in withdrawal — the tool is designed for alcohol, not benzodiazepine or other sedative withdrawal.
- Score each of the 10 items from direct observation and brief questioning at the bedside. Items 1–9 are scored 0–7; item 10 (orientation/sensorium) is scored 0–4.
- The total score (0–67) and severity band update automatically. Re-score every 1–8 hours depending on severity.
- Use the score to drive symptom-triggered benzodiazepine dosing: typical thresholds are CIWA-Ar ≥ 8–10 for a dose, with escalation for ≥ 19.
All computation runs in your browser; no values are stored or transmitted.
When to Use
Use the CIWA-Ar in adult patients with a documented history of recent heavy alcohol use who are now in or at risk of acute withdrawal. It grades severity so that benzodiazepines are given when symptoms warrant and withheld when they do not — the symptom-triggered approach, which shortens treatment duration and reduces total benzodiazepine exposure compared with fixed-schedule regimens.
Appropriate population
Awake, oriented adults who can cooperate with brief questioning (orientation, hallucinations, headache) and whose alcohol use is known. Use for monitoring in the emergency department, medical wards, detoxification units, or outpatient supervised withdrawal when the patient can describe symptoms.
When NOT to rely on it
The CIWA-Ar depends on patient report for several items (nausea, tactile/auditory/visual disturbances, headache, orientation). It is not valid in patients who cannot communicate — intubated, obtunded, delirious, severely demented, or with language barriers — and it is not designed for withdrawal from benzodiazepines, opioids, or other sedatives. In unable-to-communicate patients, use a behavioral tool (e.g., RASS with clinical judgment) instead. The scale also does not replace clinical assessment for seizures or delirium tremens, which can occur at any score and require immediate escalation.
Pearls & Pitfalls
Symptom-triggered beats fixed-schedule dosing
In cooperative patients, symptom-triggered benzodiazepine dosing driven by the CIWA-Ar halves treatment duration and total benzodiazepine dose versus fixed-schedule regimens, without increasing complications. Typical trigger is a score of 8 or 10, with reassessment in roughly 1 hour and re-dosing while the score remains above threshold.
Bedside tips
Items 2 (tremor) and 10 (orientation) are the most objective — anchor your assessment there and score them first. Score the hallucination items (6, 7, 8) based on what the patient actually reports; do not inflate them for mere "sensitivity" that is briefly annoying rather than distressing. Reassess every hour while scores are moderate to severe and every 4–8 hours when scores are minimal.
Pitfalls
(1) CIWA-Ar is not a diagnostic test for withdrawal — pain, anxiety, and sympathomimetic use can all elevate the score. Start with a documented history of recent heavy alcohol use. (2) The scale under-performs in non-communicative patients (intubated, obtunded, severely delirious) — use a behavioral scale and clinical judgment instead. (3) A low or falling score does not exclude impending seizures or delirium tremens; these can occur abruptly. (4) Thiamine (IV, before any carbohydrate load) is given to all patients at risk of Wernicke encephalopathy independent of the CIWA-Ar score. (5) Patients on beta-blockers or alpha-2 agonists may have blunted tremor and vital-sign changes and under-score for severity.
Why Use It
Acute alcohol withdrawal spans a wide clinical spectrum, from mild tremor and anxiety to seizures and delirium tremens with a non-trivial mortality. The CIWA-Ar converts the bedside picture into a reproducible number, which lets clinicians give benzodiazepines in proportion to severity rather than on a fixed schedule — the regimen that has repeatedly been shown to shorten treatment and reduce total sedative exposure. The scale also gives a shared vocabulary across shifts and services (ED, ward, detoxification unit) and raises an early alarm — a score of 19 or more — in the patients at highest risk of seizures and delirium, prompting closer monitoring and more aggressive pharmacotherapy. The 2020 ASAM Clinical Practice Guideline on Alcohol Withdrawal Management continues to endorse symptom-triggered benzodiazepine therapy driven by a validated scale such as the CIWA-Ar as the standard of care in cooperative patients.
CIWA-Ar — Alcohol Withdrawal Assessment
Score each of the 10 observational items. The total (0–67) and the severity band update automatically. Use the score to guide symptom-triggered benzodiazepine dosing and the frequency of reassessment.
⚕ Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). Br J Addict. 1989;84(11):1353–1357. The CIWA-Ar grades severity to drive symptom-triggered treatment; it does not diagnose alcohol withdrawal. Always confirm recent heavy alcohol use, rule out alternative diagnoses (sepsis, intracranial process, metabolic derangement), give parenteral thiamine when at risk of Wernicke, and escalate for seizures or delirium regardless of score. For licensed clinicians; not a substitute for individualized assessment.
Next Steps
Use the total score to pick the intensity of pharmacotherapy and monitoring.
- Score below 10 — minimal to mild withdrawal: supportive care — quiet environment, hydration, nutrition, parenteral thiamine, and reassurance. No benzodiazepine indicated at this level. Reassess every 4–8 hours.
- Score 10–18 — moderate withdrawal: start symptom-triggered benzodiazepines (e.g., diazepam 10–20 mg PO or lorazepam 2–4 mg PO). Reassess in approximately 1 hour and re-dose while the score remains at or above the chosen trigger (typically 8 or 10). Favor lorazepam in significant hepatic disease or in older adults.
- Score 19 or above — severe withdrawal: aggressive benzodiazepine therapy with close monitoring; consider admission to a higher-acuity unit or ICU, telemetry, and a propensity to seizures and delirium tremens. Add adjunctive agents (e.g., alpha-2 agonists for sympathetic overdrive, antipsychotics only for severe agitation on top of benzodiazepines) per institutional protocol.
- At every level: give IV thiamine (typically 100 mg or more) before any carbohydrate load, correct electrolytes (K, Mg, phosphate), screen for concurrent infection or trauma, and address alcohol use disorder once the acute episode has settled.
- Pair the CIWA-Ar with the COWS when opioid co-use is suspected, and with routine Cockcroft–Gault dose-adjustment for comorbid kidney disease.
Evidence & References
Scoring
| Item | Range |
|---|---|
| 1. Nausea and vomiting | 0–7 |
| 2. Tremor | 0–7 |
| 3. Paroxysmal sweats | 0–7 |
| 4. Anxiety | 0–7 |
| 5. Agitation | 0–7 |
| 6. Tactile disturbances | 0–7 |
| 7. Auditory disturbances | 0–7 |
| 8. Visual disturbances | 0–7 |
| 9. Headache, fullness in head | 0–7 |
| 10. Orientation and clouding of sensorium | 0–4 |
| Total | 0–67 |
Severity Bands
| Total score | Severity | Action |
|---|---|---|
| Below 10 | Minimal to mild | Supportive care only; no benzodiazepine indicated; reassess every 4–8 hours. |
| 10–18 | Moderate | Symptom-triggered benzodiazepine (e.g., diazepam 10–20 mg PO or lorazepam 2–4 mg PO); reassess in approximately 1 hour. |
| 19 or above | Severe | High risk of seizures and delirium tremens; aggressive benzodiazepine therapy; close monitoring; consider ICU. |
The commonly used symptom-triggered protocols give a benzodiazepine dose when the total score is at or above 8 (or 10 depending on local policy), and re-dose every hour while the score stays at or above threshold.
References
- Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). Br J Addict. 1989;84(11):1353–1357. doi:10.1111/j.1360-0443.1989.tb00737.x.
- Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA. 1997;278(2):144–151. doi:10.1001/jama.1997.03550020076042.
- The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. J Addict Med. 2020;14(3S Suppl 1):1–72.
